NCT06193889 2026-04-06
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Kyverna Therapeutics
Phase 2/3 Recruiting
Clinical Trials
19 trialsNCT07039916 2026-03-06
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Immunovant Sciences GmbH
Phase 3 Recruiting
NCT06626919 2026-02-25
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Arcellx, Inc.
Phase 1 Recruiting
NCT06359041 2026-02-20
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Cabaletta Bio
Phase 1/2 Active not recruiting
NCT05451212 2025-11-10
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Cabaletta Bio
Phase 1 Completed
NCT05737160 2025-05-23
Study of Telitacicept in Generalized Myasthenia Gravis
RemeGen Co., Ltd.
Phase 3 Completed
NCT04176211 2024-06-03
The Impact of Myasthenia Gravis in the Real World
Vitaccess Ltd
Completed
NCT03283826 2024-02-23
EMBOLD
Atara Biotherapeutics
Phase 1/2 Terminated
NCT06035614 2023-09-13
Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children
Clarteis
Phase NA Completed
NCT05889806 2023-06-05
AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
Audubon Bioscience
Enrolling by invitation
NCT03884400 2022-11-14
Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
iSpecimen Inc
Withdrawn
NCT03848962 2022-11-09
Collection and Distribution of Biospecimens for Novel Research Uses
iSpecimen Inc
Recruiting
NCT05080907 2022-11-09
Collection and Distribution of Biospecimens for Novel Research
iSpecimen Inc
Unknown
NCT03348046 2020-03-04
PASSRRA
Hikma Pharmaceuticals LLC
Completed
NCT01953822 2016-12-26
Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom
GlaxoSmithKline
Completed
NCT01498627 2015-04-06
PGRx
GlaxoSmithKline
Completed
NCT01153906 2014-12-02
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination
GlaxoSmithKline
Completed
NCT00731536 2013-10-16
Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands
Centocor Ortho Biotech Services, L.L.C.
Completed
NCT01210716 2013-09-23
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
Fenwal, Inc.
Phase 3 Completed